These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 24872416)
61. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Kim MH; Yoo DS; Lee SY; Byeon SE; Lee YG; Min T; Rho HS; Rhee MH; Lee J; Cho JY Pharmazie; 2011 Apr; 66(4):293-300. PubMed ID: 21612158 [TBL] [Abstract][Full Text] [Related]
62. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662 [TBL] [Abstract][Full Text] [Related]
63. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226 [TBL] [Abstract][Full Text] [Related]
64. SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter. Gürtler C; Carty M; Kearney J; Schattgen SA; Ding A; Fitzgerald KA; Bowie AG J Immunol; 2014 May; 192(10):4821-32. PubMed ID: 24711619 [TBL] [Abstract][Full Text] [Related]
68. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. Lee SM; Kim EJ; Suk K; Lee WH J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801 [TBL] [Abstract][Full Text] [Related]
69. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. Tsuboi N; Yoshikai Y; Matsuo S; Kikuchi T; Iwami K; Nagai Y; Takeuchi O; Akira S; Matsuguchi T J Immunol; 2002 Aug; 169(4):2026-33. PubMed ID: 12165529 [TBL] [Abstract][Full Text] [Related]
70. TRAM is required for TLR2 endosomal signaling to type I IFN induction. Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819 [TBL] [Abstract][Full Text] [Related]
71. Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1. Kim AY; Shim HJ; Shin HM; Lee YJ; Nam H; Kim SY; Youn HS Int Immunopharmacol; 2018 Apr; 57():172-180. PubMed ID: 29518743 [TBL] [Abstract][Full Text] [Related]
72. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Yokoyama T; Komori A; Nakamura M; Takii Y; Kamihira T; Shimoda S; Mori T; Fujiwara S; Koyabu M; Taniguchi K; Fujioka H; Migita K; Yatsuhashi H; Ishibashi H Liver Int; 2006 May; 26(4):467-76. PubMed ID: 16629651 [TBL] [Abstract][Full Text] [Related]
73. Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages. Bradley WP; Boyer MA; Nguyen HT; Birdwell LD; Yu J; Ribeiro JM; Weiss SR; Zamboni DS; Roy CR; Shin S Infect Immun; 2016 Apr; 84(4):998-1015. PubMed ID: 26787725 [TBL] [Abstract][Full Text] [Related]
74. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart. Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060 [TBL] [Abstract][Full Text] [Related]
75. Toll-Like Receptor 2, Toll-Like Receptor 4, Myeloid Differentiation Response Gene 88, and Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing Interferon-γ (TRIF) Selectively Regulate Susceptibility of P0 Brunn A; Mihelcic M; Carstov M; Feind L; Wieser EC; Schmidt J; Utermöhlen O; Deckert M Am J Pathol; 2017 Jan; 187(1):42-54. PubMed ID: 27842213 [TBL] [Abstract][Full Text] [Related]